News

ThePrint on MSN1h
Blockbuster semaglutide set to go off patent, Indian pharma sees a multi-billion-dollar opportunity
Pharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and ...
2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold at Least a Decade
Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Most dividend yields ...
Novo Nordisk is in trouble: the reasons why Ozempic is losing millions of dollars in sales
Once the golden child of the weight-loss boom, the Danish drugmaker now faces a painful financial slimming of its own.
TipRanks on MSN19h
‘Time to Double Down,’ Says Top Investor About Novo Nordisk Stock
It has been a rough few seasons for Novo Nordisk (NYSE:NVO) investors, as the company’s share price has tumbled some 60% over ...
Rise of ‘faux-zempic’ fake weight loss drugs being imported into UK black market & sold on social media…how to spot dupe
WEIGHT-LOSS drugs can be a silver bullet for some trying to shed the pounds after years of failure with fad diets and exercise routines. But dodgy vendors selling potentially deadly fake jabs ...